Mortality-Related Risk Factors and Novel Antimicrobial Regimens for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review-Reference-Cited by-同舟云学术

Mortality-Related Risk Factors and Novel Antimicrobial Regimens for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review

Published:2022-11 Issue: Volume:Volume 15 Page:6907-6926
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Hu Qin,Chen Jinglan,Sun Shusen^ORCID,Deng Sheng

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference86 articles.

1. Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

2. Centers for Disease Control and Prevention Facility. Guidance for control of carbapenem resistant Enterobacteriaceae (CRE)ō; 2015. Available from: https://www.cdc.gov/hai/organisms/cre/. Accessed November 22, 2022.

3. Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections

4. Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China

5. Outbreak of Klebsiella pneumoniae carbapenemase–producing K pneumoniae: A systematic review

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiological Characteristics and Drug Resistance Analysis of 187 Strains of Carbapenem-Resistant Enterobacteriaceae in a General Hospital;Jundishapur Journal of Microbiology;2024-09-14

2. Carbapenem-resistant Enterobacterales sepsis following endoscopic retrograde cholangiopancreatography: risk factors for 30-day all-cause mortality and the development of a nomogram based on a retrospective cohort;Antimicrobial Resistance & Infection Control;2024-08-07

3. Indian consensus on the management of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II);Expert Review of Anti-infective Therapy;2024-05-27

4. Comparative effectiveness and mortality of colistin monotherapy versus colistin-fosfomycin combination therapy for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections: A propensity score analysis;Journal of Infection and Public Health;2024-05

5. Ceftazidime/avibactam serum concentration in patients on ECMO;Journal of Antimicrobial Chemotherapy;2024-03-28